Argan Slides as Investors Weigh Strong Results Against Backlog and Valuation Concerns

Argan, Inc. (AGX) is down 7.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be a continued reset in expectations after last week’s earnings, as investors balance Argan’s strong quarterly growth against a smaller project backlog and concerns about how long current margins can hold. This could also be because the stock had rallied sharply before the recent pullback, leaving little room for any sign of softer future contract timing.

Details:

Argan’s September 2 earnings release showed record quarterly revenue of about $384 million and record net income of about $53 million, with diluted EPS of $3.76.

Despite that strong quarter, project backlog stood at about $2.52 billion on July 31, 2026, down from about $2.93 billion at January 31, 2026, suggesting investors are focusing on future award timing.

The company’s filing also noted that new projects are often added to backlog only after notices to proceed are received, and that project starts are controlled largely by customers, which can create timing uncertainty.

Recent market commentary has highlighted backlog cadence, margin durability, and valuation as key risks after the stock’s earlier surge, which fits the pattern of a post-earnings comedown rather than a new company-specific shock today.

Sources:

SEC, Zacks, Yahoo Finance

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$AGX Insider Trading Activity

$AGX insiders have traded $AGX stock on the open market 23 times in the past 6 months. Of those trades, 0 have been purchases and 23 have been sales.

Here’s a breakdown of recent trading of $AGX stock by insiders over the last 6 months:

WILLIAM F JR GRIFFIN has made 0 purchases and 2 sales selling 50,000 shares for an estimated $36,984,100.
DAVID HIBBERT WATSON (PRESIDENT AND CEO) has made 0 purchases and 3 sales selling 31,183 shares for an estimated $19,464,203.
WILLIAM F. LEIMKUHLER has made 0 purchases and 4 sales selling 14,244 shares for an estimated $8,636,599.
CHARLES EDWIN IV COLLINS (CHIEF EXECUTIVE OFFICER, GEMMA) has made 0 purchases and 2 sales selling 13,568 shares for an estimated $8,404,979.
PETER W GETSINGER has made 0 purchases and 4 sales selling 12,309 shares for an estimated $8,060,173.
JOHN RONALD JR. JEFFREY has made 0 purchases and 2 sales selling 6,334 shares for an estimated $4,031,332.
CYNTHIA FLANDERS sold 2,596 shares for an estimated $1,729,740
JOSHUA SCOTT BAUGHER (Chief Financial Officer) has made 0 purchases and 3 sales selling 1,360 shares for an estimated $920,667.
ALEXANDER LISA LARROQUE sold 350 shares for an estimated $220,703
KAREN SWEENEY sold 300 shares for an estimated $211,500

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$AGX Hedge Fund Activity

We have seen 310 institutional investors add shares of $AGX stock to their portfolio, and 294 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

MAVERICK CAPITAL LTD removed 464,759 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $371,133,299
PRICE T ROWE ASSOCIATES INC /MD/ added 328,238 shares (+357.3%) to their portfolio in Q2 2026, for an estimated $262,114,454
UBS GROUP AG removed 167,175 shares (-51.6%) from their portfolio in Q2 2026, for an estimated $133,497,596
SURGOCAP PARTNERS LP added 149,983 shares (+inf%) to their portfolio in Q2 2026, for an estimated $119,768,924
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 144,771 shares (+inf%) to their portfolio in Q2 2026, for an estimated $115,606,882
BANK OF NEW YORK MELLON CORP removed 135,232 shares (-45.0%) from their portfolio in Q2 2026, for an estimated $107,989,513
VALUE ALIGNED RESEARCH ADVISORS, LLC removed 128,858 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $68,341,128

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$AGX Congressional Stock Trading

Members of Congress have traded $AGX stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $AGX stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $50,000 on 06/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$AGX Price Targets

Multiple analysts have issued price targets for $AGX recently. We have seen 3 analysts offer price targets for $AGX in the last 6 months, with a median target of $550.0.

Here are some recent targets:

Robert Brown from Lake Street set a target price of $600.0 on 06/05/2026
Michael Fairbanks from JP Morgan set a target price of $550.0 on 03/27/2026
Atidrip Modak from Goldman Sachs set a target price of $518.0 on 03/27/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.